The Aggregation Inhibitor Peptide QBP1 as a Therapeutic Molecule for the Polyglutamine Neurodegenerative Diseases

Misfolding and abnormal aggregation of proteins in the brain are implicated in the pathogenesis of various neurodegenerative diseases including Alzheimer's, Parkinson's, and the polyglutamine (polyQ) diseases. In the polyQ diseases, an abnormally expanded polyQ stretch triggers misfolding...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Popiel, H. Akiko, Burke, James R., Strittmatter, Warren J., Oishi, Shinya, Fujii, Nobutaka, Takeuchi, Toshihide, Toda, Tatsushi, Wada, Keiji, Nagai, Yoshitaka
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE-Hindawi Access to Research 2011
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3268222/
https://ncbi.nlm.nih.gov/pubmed/22312459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4061/2011/265084
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak